[1S-(1Alpha,2Alpha,3Beta,5Alpha)]-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
CAS: 110567-22-1
Ref. TR-P335720
50mg | 142.00 € | ||
100mg | 228.00 € | ||
250mg | 493.00 € |
Product Information
- (1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane
- (1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
- (1S,2R,3S,5R)-3-(benzyloxy)-2-((4-methylbenzyloxy)methyl)-6-oxabicyclo[3.1.0]hexane
- (1S,2R,3S,5R)-3-(benzyloxy)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexane
- 6-Oxabicyclo[3.1.0]hexane, 3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2R,3S,5R)-
- 6-Oxabicyclo[3.1.0]hexane, 3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, [1S-(1α,2α,3β,5α)]-
- Ent-3
- Entecavir intermediate 3
- Entecavir intermediate N3
- [1S-(1a,2a,3,5a)]-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
- See more synonyms
Applications Entecavir intermediate.
References Bisacchi, G., et al.: Bioorg. Med. Chem. Lett., 7, 127 (1997), Innaimo, S., et al.: Antimicrob. Agents Chemother., 41, 1444 (1997), Galan, M., et al.: Expert. Opin. Pharmacother., 2(8), 1289 (2001), Delaney, W., et al.: Expert Opin. Invest. Drug., 11, 169 (2002),
Chemical properties
Technical inquiry about: TR-P335720 [1S-(1Alpha,2Alpha,3Beta,5Alpha)]-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.